Drug maker GlaxoSmithKline (GSK) "plans to bolster earnings by selling to more people in middle-income countries after cutting prices in the world's poorest nations," Bloomberg/BusinessWeek reports. "Our strategy is to grow our business in middle-income countries by increasing the volume of products we sell," GSK Chief Executive Andrew Witty said by e-mail, according to the news service... 
More...
More...